Journal article Published 2023

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors

M.A. Wazynska, R. Butera, M. Requesens, A. Plat, T. Zarganes-Tzitzikas, C.G. Neochoritis, J. Plewka, L. Skalniak, J. Kocik-Krol, B. Musielak, K. Magiera-Mularz, I. Rodriguez, S.N. Blok, M. de Bryun, H.W. Nijman,

Show all 18 authors

P.H. Elsinga, T.A. Holak, Alexander Dömling

Journal of Medicinal Chemistry 66(14), 9577-9591 (2023)

View on PubMed Cite

2023 Year
37450644 PMID

Cite this publication

WAZYNSKA, M., R. BUTERA, M. REQUESENS, A. PLAT, T. ZARGANES-TZITZIKAS, C. NEOCHORITIS, J. PLEWKA, L. SKALNIAK, J. KOCIK-KROL, B. MUSIELAK, K. MAGIERA-MULARZ, I. RODRIGUEZ, S. BLOK, M. DE BRYUN, H. NIJMAN, P. ELSINGA, T. HOLAK, A. DÖMLING: Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors. Journal of Medicinal Chemistry. 2023, 66(14), 9577-9591, ISSN: 0022-2623, PMID: 37450644.

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors

Cite this publication

Details

Authors from EATRIS